Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Antidiarrheal Action of Bacillus subtilis CU1 CNCM I-2745 and Lactobacillus plantarum CNCM I-4547 in Mice.

Urdaci MC, Lefevre M, Lafforgue G, Cartier C, Rodriguez B, Fioramonti J.

Front Microbiol. 2018 Jul 10;9:1537. doi: 10.3389/fmicb.2018.01537. eCollection 2018.

2.

Recent advances in understanding and managing acute pancreatitis.

Mandalia A, Wamsteker EJ, DiMagno M.

F1000Res. 2018 Jun 28;7. pii: F1000 Faculty Rev-959. doi: 10.12688/f1000research.14244.1. eCollection 2018. Review.

3.

Prevalence and dynamics of Lactobacillus sp. in the lower respiratory tract of patients with cystic fibrosis.

Fangous MS, Lazzouni I, Alexandre Y, Gouriou S, Boisramé S, Vallet S, Le Bihan J, Ramel S, Héry-Arnaud G, Le Berre R.

Res Microbiol. 2018 May - Jun;169(4-5):222-226. doi: 10.1016/j.resmic.2018.03.005. Epub 2018 May 23.

PMID:
29800681
4.

Host-Microbe Interactions in Airway Disease: toward Disease Mechanisms and Novel Therapeutic Strategies.

Cope EK.

mSystems. 2018 Mar 13;3(2). pii: e00158-17. doi: 10.1128/mSystems.00158-17. eCollection 2018 Mar-Apr.

5.

A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.

Vernocchi P, Del Chierico F, Quagliariello A, Ercolini D, Lucidi V, Putignani L.

Nutrients. 2017 Dec 9;9(12). pii: E1342. doi: 10.3390/nu9121342.

6.

Clinical effects of probiotics in cystic fibrosis patients: A systematic review.

Van Biervliet S, Declercq D, Somerset S.

Clin Nutr ESPEN. 2017 Apr;18:37-43. doi: 10.1016/j.clnesp.2017.01.007. Epub 2017 Feb 22. Review.

PMID:
29132736
7.

Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial.

Bruzzese E, Raia V, Ruberto E, Scotto R, Giannattasio A, Bruzzese D, Cavicchi MC, Francalanci M, Colombo C, Faelli N, Daccò V, Magazzù G, Costa S, Lucidi V, Majo F, Guarino A.

J Cyst Fibros. 2018 May;17(3):375-382. doi: 10.1016/j.jcf.2017.10.014. Epub 2017 Nov 8.

PMID:
29128317
8.

Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine.

Dorsey J, Gonska T.

J Cyst Fibros. 2017 Nov;16 Suppl 2:S14-S23. doi: 10.1016/j.jcf.2017.07.014. Review.

PMID:
28986022
9.

Exploring probiotic use in a regional cystic fibrosis consortium.

Gonzalez KD, Zuckerman JB, Sears EH, Prato BS, Guill M, Craig W, Milliard C, Parker E, Lever T, Griffin MM, Leclair LW.

J Cyst Fibros. 2018 Mar;17(2):e20-e21. doi: 10.1016/j.jcf.2017.07.018. Epub 2017 Aug 16. No abstract available.

PMID:
28822727
10.

Effects of new and emerging therapies on gastrointestinal outcomes in cystic fibrosis.

Houwen RHJ, van der Woerd WL, Slae M, Wilschanski M.

Curr Opin Pulm Med. 2017 Nov;23(6):551-555. doi: 10.1097/MCP.0000000000000423. Review.

PMID:
28787381
11.

Does probiotic supplementation affect pulmonary exacerbation and intestinal inflammation in cystic fibrosis: a systematic review of randomized clinical trials.

Nikniaz Z, Nikniaz L, Bilan N, Somi MH, Faramarzi E.

World J Pediatr. 2017 Aug;13(4):307-313. doi: 10.1007/s12519-017-0033-6. Epub 2017 Apr 29. Review.

PMID:
28470579
12.

The altered gut microbiota in adults with cystic fibrosis.

Burke DG, Fouhy F, Harrison MJ, Rea MC, Cotter PD, O'Sullivan O, Stanton C, Hill C, Shanahan F, Plant BJ, Ross RP.

BMC Microbiol. 2017 Mar 9;17(1):58. doi: 10.1186/s12866-017-0968-8. Erratum in: BMC Microbiol. 2017 Apr 27;17 (1):102.

14.

The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.

Garg M, Ooi CY.

Curr Gastroenterol Rep. 2017 Feb;19(2):6. doi: 10.1007/s11894-017-0546-0. Review.

PMID:
28155088
15.

Complementary and alternative medicine use in children with cystic fibrosis.

Giangioppo S, Kalaci O, Radhakrishnan A, Fleischer E, Itterman J, Lyttle B, Price A, Radhakrishnan D.

Complement Ther Clin Pract. 2016 Nov;25:68-74. doi: 10.1016/j.ctcp.2016.08.006. Epub 2016 Aug 15.

PMID:
27863612
16.

Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: A systematic review.

Anderson JL, Miles C, Tierney AC.

J Cyst Fibros. 2017 Mar;16(2):186-197. doi: 10.1016/j.jcf.2016.09.004. Epub 2016 Sep 29. Review.

PMID:
27693010
17.

Probiotic supplementation in children with cystic fibrosis-a systematic review.

Ananthan A, Balasubramanian H, Rao S, Patole S.

Eur J Pediatr. 2016 Oct;175(10):1255-66. doi: 10.1007/s00431-016-2769-8. Epub 2016 Aug 30. Review.

PMID:
27576473
18.

Wheat bran components modulate intestinal bacteria and gene expression of barrier function relevant proteins in a piglet model.

Chen H, Chen D, Qin W, Liu Y, Che L, Huang Z, Luo Y, Zhang Q, Lin D, Liu Y, Han G, DeSmet S, Michiels J.

Int J Food Sci Nutr. 2017 Feb;68(1):65-72. doi: 10.1080/09637486.2016.1212817. Epub 2016 Aug 2.

PMID:
27484261
19.

Pathogen-induced secretory diarrhea and its prevention.

Anand S, Mandal S, Patil P, Tomar SK.

Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1721-1739. Epub 2016 Jul 29. Review.

PMID:
27473379
20.

ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis.

Turck D, Braegger CP, Colombo C, Declercq D, Morton A, Pancheva R, Robberecht E, Stern M, Strandvik B, Wolfe S, Schneider SM, Wilschanski M.

Clin Nutr. 2016 Jun;35(3):557-77. doi: 10.1016/j.clnu.2016.03.004. Epub 2016 Mar 15.

PMID:
27068495

Supplemental Content

Loading ...
Support Center